Company_Context
Healthcare
Drug Manufacturers
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Signal_Window
Headline metrics use exact calendar-day windows.
19 directional transactions in 90D
Code P purchases and code S sales are measured from 2026.07.20 — 2026.10.17.
-$14.7M
Open-market buys minus sales2026.10.01
Latest available filing9
Reporting entities in windowNo 90D buyer
No open-market buys in 90DCAGNONI PABLO J
$8.7MAnalysis of eligible SEC Form 4 activity for INCY indicates a bearish 90-day signal. The selected window contains transactions from 9 distinct reporting insiders, with aggregate nominal activity of $20.32M.
Open-market purchases minus open-market sales produce a negative net flow of $14.67M. Open-market executions represent the majority of measured nominal activity in this window, making the directional flow more representative of voluntary trading activity.
The largest open-market sale in the selected window was attributed to CAGNONI PABLO J (President, Global Head of R&D). Form 4 activity provides useful ownership context, but it should not be treated as a standalone prediction of future price performance.
Enriched_Research_Context
These indicators use normalized SEC roles, issuer metadata, cluster detection and post-filing market prices already calculated by the data pipeline.
Healthcare
Drug Manufacturers
0
Clustered open-market purchase records in the recent filing sample.
Unlock a $15 subscription discount
For eligible new users purchasing a subscription through this link. TradingView terms apply.
Affiliate link — InsiderAlpha may earn a commission at no additional cost to you.
Recent_Filing_History
This table shows recent filing history and is not restricted by the selected 90D headline signal window.
During the last 90 calendar days, eligible open-market sales total $14.67M. CAGNONI PABLO J recorded the largest aggregate selling volume.
The 90-day open-market signal is BEARISH, with net flow of $14.67M across 9 reporting insiders in the selected window.
The most recent insider transaction on record was filed on 2026.10.01. InsiderAlpha monitors EDGAR filings and updates this terminal as new Form 4 documents are published.
Performance pending
No matured open-market transaction with calculated market windows is available in the recent sample.
Performance uses the latest matured open-market record in this sample. It describes subsequent market movement and does not imply that the filing caused the price change.